The term "growth stock" has historically been applied to publicly traded companies in industries that are expanding because of broad societal forces, rather than just competitive pressures or economic cycles.

The problem for conservative investors is that these industries -- such as pharmaceuticals and consumer nondurable goods -- are getting harder to find as once-solid double-digit returns in these sectors have been stymied.

Limited Time Offer

Save $400 off your subscription. Special offer ends April 30, 2017.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.